Skip to content
Medical Health Aged Care

Bullwinkel Scholarships honour memory of massacred war nurses

Australian College of Nursing 2 mins read

The inaugural Australian College of Nursing Foundations’ Bullwinkel Scholars Program will award 22 scholarships to nurse leaders on Friday at a presentation at Duntroon House at the Royal Military College in Canberra.


The ‘Bullwinkel Scholarships’ honour the legacy of Lieutenant Colonel Vivian Bullwinkel and her 21 brave nursing colleagues. They are valued at up to $10,000 each and will contribute to nursing leadership education and professional development.


The ceremony will coincide with the 82nd anniversary of the Bangka Island massacre which occurred on 16 February 1942 and where Lt Col Vivian Bullwinkel was the sole survivor.


The 22 scholarships carry the names of the 21 fallen nurses, plus one for the sole survivor, Lt Col Vivian Bullwinkel whose statue now stands in tribute at the Australian War Memorial.


The Assistant Minister for Health and Aged Care, the Hon Ged Kearney MP; Chief of the Defence Force, General Angus Campbell AO DSC; and John Bullwinkel, nephew of Lt Col Vivian Bullwinkel, will officiate at the ceremony.


Media are welcome to attend, please RSVP to: Christine Klomp,


ACN Foundation Bullwinkel Scholars Presentation

Time:                  5.30pm AEDT

Date:                  Friday 16 February 2024

Venue:               Duntroon House

                             Royal Military College

                             Parnell Road

                             CAMPBELL ACT

Images to follow event.


For more information:

Jessica Kauffman 0400 433 182



Notes to Editors:

The Australian College of Nursing (ACN) Foundation is dedicated to ensuring Australian nurses have access to educational, research, advocacy and leadership opportunities that will keep them highly skilled and at the cutting edge of healthcare delivery.


The ACN Foundation is able to support Australian nurses and the profession in achieving the highest level of nursing excellence thanks to the generous support of corporations, individuals, and private Trusts and Foundations.


Social media channels:            Facebook:



More from this category

  • Medical Health Aged Care, Science
  • 17/07/2024
  • 14:00
De Motu Cordis

De Motu Cordis (DMC) announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product

Brisbane, QLD – 17 July 2024 – De Motu Cordis (DMC) today announced plans for the next stage of development with its Contract Development and Manufacturing Organization (CDMO) partner, Catalent, at Catalent’s Boston, Morrisville and San Diego sites. These expansion plans encompass services from drug product manufacturing and device assembly through to commercial launch of DMC’s product, DMC-IH1. DMC-IH1 is an inhaled epinephrine drug-device combination product being developed for the treatment of anaphylaxis using a dry powder inhaler (DPI). Catalent DPI drug delivery services offer end-to-end solutions to bring customers through the entire clinical pharma journey by leveraging the commercial…

  • Medical Health Aged Care, Women
  • 17/07/2024
  • 07:00
Monash University

Study underlines the importance of supporting primary care clinicians to deliver early medical abortion and long acting reversible contraception

The impetus for additional support and training for clinicians wanting to deliver important sexual and reproductive services has received a boost with the release of Monash University-led research. Published in BMJ – Sexual and Reproductive Health, the AusCAPPS study found that GPs, nurses and pharmacists seek peer support and online resources to deliver long-acting reversible contraception (LARC) and early medical abortion (EMA) in Australian primary care.Experienced and emerging providers of LARC and EMA sought support regarding clinical issues online from AusCAPPS, which is the Australian Contraception and Abortion Primary Care Practitioner Support Network, an evidence-based virtual community of practice launched…

  • Medical Health Aged Care
  • 17/07/2024
  • 03:11
Interrad Medical, Inc.

Interrad Medical’s SecurAcath is Superior to Standard of Care in Newly Published Randomized Controlled Clinical Study

PLYMOUTH, Minn.–BUSINESS WIRE– Interrad Medical, Inc., a privately held medical device company, announces excellent results of a clinical study published in JAMA Pediatrics titled,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.